Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Chris Lange | May 23, 2019 at 10:35 AM EDT

How Tonix Pharma Is Kicking Cocaine

Tonix Pharmaceuticals shares jumped on Thursday after the firm announced that it has in-licensed a Phase 2 asset, TNX-1300 for…

Chris Lange | May 22, 2019 at 11:40 AM EDT

How Eli Lilly Is Making Insulin More Affordable

Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use…

Chris Lange | May 21, 2019 at 1:40 PM EDT

Why Ocular Therapeutix Fell Short in Its Glaucoma Study

Ocular Therapeutix shares took a beating on Tuesday after the firm announced late-stage results for patients with primary open-angle glaucoma…

Chris Lange | May 21, 2019 at 10:10 AM EDT

Why BioCryst’s HAE Treatment Failed to Impress

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary…

Paul Ausick | May 20, 2019 at 11:13 AM EDT

We May Have Been Wrong About the Connection Between Coffee and Poop for Years

New research indicates that caffeine may not be the reason that some coffee drinkers feel a need for a bowel…

Chris Lange | May 16, 2019 at 4:03 PM EDT

Thursday’s Top 4 ASCO Movers

This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and…

Jon C. Ogg | May 16, 2019 at 2:10 PM EDT

Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?

If there is one former Dow Jones industrial average leader that is in need of serious help, look no further…

Chris Lange | May 16, 2019 at 11:35 AM EDT

Solid Breast Cancer Results From MacroGenics Ahead of ASCO

MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic…

Hristina Byrnes | May 16, 2019 at 11:29 AM EDT

These Are the Most Used Drugs in the World — And Opioids Aren’t Even in the Top 5

About 53 million people worldwide use opioids or their natural counterparts and nearly half of them develop substance-abuse disorders leading…

Chris Lange | May 16, 2019 at 9:55 AM EDT

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Iovance Biotherapeutics is one of the early big winners from ASCO. The firm announced updates from ongoing clinical trials including…

Paul Ausick | May 15, 2019 at 12:30 PM EDT

Why Agilent Stock Plunged 12% After Earnings

Health care instrument maker Agilent is getting hammered Wednesday following a worse-than-expected earnings report for the company's second fiscal quarter.…